# Digital Diabetes Prevention Program Study

> **NCT06137963** · NA · WITHDRAWN · sponsor: **Hospital for Special Surgery, New York**

## Conditions studied

- PreDiabetes

## Interventions

- **OTHER:** Transform10 Diabetes Prevention Program

## Key facts

- **NCT ID:** NCT06137963
- **Lead sponsor:** Hospital for Special Surgery, New York
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2024-01-24
- **Primary completion:** 2024-04-04
- **Final completion:** 2024-04-04
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** This study is no longer feasible due to the increasing number of diabetic patients who are prescribed Ozempic and other GLP-1 agonists.
- **Last updated:** 2024-12-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06137963

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06137963, "Digital Diabetes Prevention Program Study". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06137963. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*